Apollo Endosurgery (Apollo Endosurgery) Days Inventory : 160.11 (As of Dec. 2022)

View and export this data going back to 2007. Start your Free Trial

What is Apollo Endosurgery Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Apollo Endosurgery's Average Total Inventories for the three months ended in Dec. 2022 was $17.47 Mil. Apollo Endosurgery's Cost of Goods Sold for the three months ended in Dec. 2022 was $9.96 Mil. Hence, Apollo Endosurgery's Days Inventory for the three months ended in Dec. 2022 was 160.11.

The historical rank and industry rank for Apollo Endosurgery's Days Inventory or its related term are showing as below:

APEN' s Days Inventory Range Over the Past 10 Years
Min: 137.01 Med: 160.17 Max: 196.82
Current: 158.79

During the past 13 years, Apollo Endosurgery's highest Days Inventory was 196.82. The lowest was 137.01. And the median was 160.17.

APEN's Days Inventory is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 190.88 vs APEN: 158.79

Apollo Endosurgery's Days Inventory increased from Dec. 2021 (150.27) to Dec. 2022 (160.11). It might indicate that Apollo Endosurgery's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Apollo Endosurgery's Inventory Turnover for the three months ended in Dec. 2022 was 0.57.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Apollo Endosurgery's Inventory-to-Revenue for the three months ended in Dec. 2022 was 0.82.

Apollo Endosurgery Days Inventory Historical Data

The historical data trend for Apollo Endosurgery's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollo Endosurgery Days Inventory Chart

Apollo Endosurgery Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Inventory

Get a 7-Day Free Trial

160.17

137.01

176.65

145.01

160.15

Apollo Endosurgery Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Days Inventory	Get a 7-Day Free Trial															150.27	157.84	152.94	162.30	160.11

Competitive Comparison of Apollo Endosurgery's Days Inventory

For the Medical Devices subindustry, Apollo Endosurgery's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apollo Endosurgery's Days Inventory Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Apollo Endosurgery's Days Inventory distribution charts can be found below:

* The bar in red indicates where Apollo Endosurgery's Days Inventory falls into.

Apollo Endosurgery Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Apollo Endosurgery's Days Inventory for the fiscal year that ended in Dec. 2022 is calculated as

	Days Inventory (A: Dec. 2022 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2021 )	+	Total Inventories (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (11.966	+	18.246)	/	2 )	/	34.429	*	365
=	15.106					/	34.429	*	365
=	160.15

Apollo Endosurgery's Days Inventory for the quarter that ended in Dec. 2022 is calculated as:

	Days Inventory (Q: Dec. 2022 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2022 )	+	Total Inventories (Q: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2022 )	*	Days in Period
=	( (16.696	+	18.246)	/	2 )	/	9.957	*	365 / 4
=	17.471					/	9.957	*	365 / 4
=	160.11

Apollo Endosurgery (NAS:APEN) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Apollo Endosurgery's Inventory Turnover for the three months ended in Dec. 2022 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	9.957	/	17.471
	=	0.57

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Apollo Endosurgery's Inventory to Revenue for the three months ended in Dec. 2022 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	17.471	/	21.314
	=	0.82

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Apollo Endosurgery Days Inventory Related Terms

Thank you for viewing the detailed overview of Apollo Endosurgery's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollo Endosurgery (Apollo Endosurgery) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Apollo Endosurgery Inc (NAS:APEN) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

1120 S. Capital of Texas Highway, Building 1, Suite 300, Austin, TX, USA, 78746

Website

https://www.apolloendo.com

Apollo Endosurgery Inc is active in the healthcare sector based in the United States. As a developer of medical devices, Apollo focuses on addressing obesity, as well as other gastrointestinal disorders. Its products are used by general surgeons, bariatric surgeons and gastroenterologists in a variety of settings to provide interventional therapy to patients who suffer from obesity. The company's products include the OverStitch Endoscopic Suturing System, X-Tack Endoscopic HeliX Tacking System, and the Orbera Intragastric Balloon System.

Executives

Antal Rohit Desai	10 percent owner	C/O PROCEPT BIOROBOTICS CORPORATION, 900 ISLAND DRIVE, REDWOOD CITY CA 94065
Sharon O'keefe	director	C/O VOCERA COMMUNICATIONS, INC., 525 RACE STREET, SAN JOSE CA 95126
Jeannette Bankes	director	ONE ALLENTOWN PARKWAY, ONE ALLENTOWN PARKWAY, ALLEN TX 75002
Jeffrey G. Black	officer: Chief Financial Officer	4955 DIRECTORS PLACE, SAN DIEGO CA 92121
Mike Gutteridge	officer: VP, Int'l Sales and Marketing	1120 S. CAPITAL OF TEXAS HIGHWAY, BUILDING 1, SUITE #300, AUSTIN TX 78746
Cpmg Inc	10 percent owner	4215 WEST LOVERS LANE, SUITE 100, DALLAS TX 75209
Mcgaughy R Kent Jr	director, 10 percent owner	500 CRESCENT COURT, SUITE 250, DALLAS TX 75201
Chas Mckhann	director, officer: President and CEO	1555 ADAMS DRIVE, C/O INTERSECT ENT, INC., MENLO PARK CA 94025
David Pacitti	director	C/O APOLLO ENDOSURGERY, INC., 1120 S., CAPITAL OF TEXAS HWY, BLDG. 1, SUITE 300, AUSTIN TX 78746
John R Barr	director	VI TECHNOLOGIES INC, 134 COOLIDGE AVENUE, WATERTOWN MA 02472
Neil Gagnon	10 percent owner	1370 AVENUE OF THE AMERICAS, 24TH FLOOR, NEW YORK NY 10019
Traweek James W Jr	10 percent owner	2000 MCKINNEY AVE, SUITE 2125, DALLAS TX 75201
Todd Newton	director, officer: Chief Executive Officer	1120 S CAPITAL OF TX HWY, BUILDING ONE, STE 300, AUSTIN TX 78746
Stonepine Capital, L.p.	10 percent owner	919 NW BOND STREET, SUITE 204, BEND OR 97703
Matthew S Crawford	director, 10 percent owner	3600 N CAPITAL OF TEXAS HWY, SUITE B180, AUSTIN TX 78746